Andrew Gibson

6.0k total citations · 1 hit paper
86 papers, 3.3k citations indexed

About

Andrew Gibson is a scholar working on Immunology, Pharmacology and Molecular Biology. According to data from OpenAlex, Andrew Gibson has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 24 papers in Pharmacology and 22 papers in Molecular Biology. Recurrent topics in Andrew Gibson's work include Drug-Induced Adverse Reactions (24 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and T-cell and B-cell Immunology (15 papers). Andrew Gibson is often cited by papers focused on Drug-Induced Adverse Reactions (24 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and T-cell and B-cell Immunology (15 papers). Andrew Gibson collaborates with scholars based in United States, United Kingdom and Australia. Andrew Gibson's co-authors include Robert P. Kimberly, Jeffrey C. Edberg, Elizabeth J. Phillips, Jianming Wu, T. Huizinga, Rudi G. J. Westendorp, Xinrui Li, Dean J. Naisbitt, Ana Maria Copaescu and Jason A. Trubiano and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Andrew Gibson

83 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis

2022 98 citations Riichiro Abe, Andrew Gibson et al. profile →

Peers

Andrew Gibson

IMMUN

RHEUM

PHARM

RNMI

Steven G. Nadler United States

Masaaki Toda Japan

Frank H. Valone United States

J. R. Kalden Germany

Daniella M. Schwartz United States

Stefano Fiore United States

Susan L. Kelley United States

Laura G. Corral United States

Clara Natoli Italy

Hugh M. Davis United States

Steven G. Nadler United States

Andrew Gibson

1.6k ×1.3

IMMUN

1.5k ×1.9

329 ×0.6

RHEUM

196 ×0.4

PHARM

381 ×1.0

RNMI

Citations per year, relative to Andrew Gibson Andrew Gibson (= 1×) peers Steven G. Nadler

Countries citing papers authored by Andrew Gibson

Since Specialization

Citations

This map shows the geographic impact of Andrew Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Gibson more than expected).

Fields of papers citing papers by Andrew Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Gibson. The network helps show where Andrew Gibson may publish in the future.

Co-authorship network of co-authors of Andrew Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Gibson. A scholar is included among the top collaborators of Andrew Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Gibson. Andrew Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gardner, Joshua, Paul Thomson, Andrew Gibson, et al.. (2025). Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS. Toxicological Sciences. 206(2). 420–432.

Gardner, Joshua, Rebecca L. Jensen, Andrew Gibson, et al.. (2024). Glycolysis: An early marker for vancomycin‐specific T‐cell activation. Clinical & Experimental Allergy. 54(1). 21–33. 3 indexed citations

Gibson, Andrew, Matthew S. Krantz, Eric Mukherjee, et al.. (2023). Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. Journal of Allergy and Clinical Immunology. 151(2). 289–300.e4. 42 indexed citations

Olsson‐Brown, Anna, Andrew Gibson, Joshua Gardner, et al.. (2021). Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. Toxicological Sciences. 186(1). 58–69. 27 indexed citations

Gibson, Andrew, Olivia Hough, Yüksel Ağca, et al.. (2021). Precocious White Matter Inflammation and Behavioural Inflexibility Precede Learning and Memory Impairment in the TgAPP21 Rat Model of Alzheimer Disease. Molecular Neurobiology. 58(10). 5014–5030. 3 indexed citations

Balko, Justin M., et al.. (2020). Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. British Journal of Clinical Pharmacology. 86(9). 1778–1789. 45 indexed citations

Jiménez‐Ruiz, Amado, et al.. (2020). Determinants of in-hospital death in patients with a thrombus straddling a patent foramen ovale: protocol of a systematic review. F1000Research. 9. 1437–1437. 1 indexed citations

Belley‐Côté, Emilie P., Richard Whitlock, Kimia Honarmand, et al.. (2019). The PROTROPIC feasibility study: prognostic value of elevated troponins in critical illness. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 66(6). 648–657. 3 indexed citations

Jones, Nicholas, et al.. (2018). C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Frontiers in Immunology. 9. 372–372. 41 indexed citations

10.

Waite, Lindsay L., Benjamin Alan Weaver, Kenneth Day, et al.. (2016). Estimation of Cell-Type Composition Including T and B Cell Subtypes for Whole Blood Methylation Microarray Data. Frontiers in Genetics. 7. 23–23. 17 indexed citations

11.

Monshi, Manal, Lee Faulkner, Andrew Gibson, et al.. (2012). Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury. Hepatology. 57(2). 727–739. 193 indexed citations

12.

Wu, Jianming, Maureen Richards, Jinhai Huang, et al.. (2011). Human FasL Gene Is a Target of β-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions. PLoS ONE. 6(10). e26143–e26143. 15 indexed citations

13.

Su, Kaihong, Hengxuan Yang, Xinrui Li, et al.. (2007). Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus. The Journal of Immunology. 178(5). 3272–3280. 152 indexed citations

14.

Qin, Hongwei, Jeffrey C. Edberg, Andrew Gibson, et al.. (2004). Differential Gene Expression Modulated by the Cytoplasmic Domain of FcγRIa (CD64) α-Chain. The Journal of Immunology. 173(10). 6211–6219. 9 indexed citations

15.

Wu, Jianming, Christine N. Metz, Xiulong Xu, et al.. (2003). A Novel Polymorphic CAAT/Enhancer-Binding Protein β Element in the FasL Gene Promoter Alters Fas Ligand Expression: A Candidate Background Gene in African American Systemic Lupus Erythematosus Patients. The Journal of Immunology. 170(1). 132–138. 184 indexed citations

16.

Pal, Ranajit, James S. Foulke, Ruth Woodward, et al.. (2003). Characterization of a Simian Human Immunodeficiency Virus Encoding the Envelope Gene from the CCR5-Tropic HIV-1 Ba-L. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(3). 300–307. 35 indexed citations

17.

Lu, Xianghuai, Robert C. Axtell, James F. Collawn, et al.. (2002). AP2 Adaptor Complex-Dependent Internalization of CD5: Differential Regulation in T and B Cells. The Journal of Immunology. 168(11). 5612–5620. 27 indexed citations

18.

Wu, Jianming, Jeffrey C. Edberg, Andrew Gibson, & Robert P. Kimberly. (2002). Conservation of FceRI gamma chain coding region in normals and in SLE patients. Lupus. 11(1). 42–45. 7 indexed citations

19.

Gibson, Andrew, Jeffrey C. Edberg, Jianming Wu, et al.. (2001). Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus. The Journal of Immunology. 166(6). 3915–3922. 319 indexed citations

20.

Hu, Zhen, et al.. (1999). Functional domain analysis of the Saccharomyces MAL-activator. Current Genetics. 36(1-2). 1–12. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact